RxSearch

NDC properties for "Cyltezo Pen 40 MG/0.8 ML Starter Pack - Psoriasis/Uveitis (4 count)" (RxCUI 2640901)

About this data

The tables show NDC propoerties for Cyltezo Pen 40 MG/0.8 ML Starter Pack - Psoriasis/Uveitis (4 count) with the RxCUI 2640901

This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product

Details for Cyltezo Pen 40 MG/0.8 ML Starter Pack - Psoriasis/Uveitis (4 count) (RxCUI 2640901)

BLABLA761058
MMSL_CODEBD32554
RxCUI2640901
SPL_SET_ID115ea79b-7209-7f19-b35d-36ec0828fbf5
Prescribable SynonymCYLTEZO Pen 40 MG/0.8 ML Starter Pack - Psoriasis/Uveitis (4 count)
RXNAV_STRCyltezo Pen 40 MG/0.8 ML Starter Pack - Psoriasis/Uveitis (4 count)
RxNorm Name{4 (0.8 ML adalimumab-adbm 50 MG/ML Auto-Injector [Cyltezo]) } Pack [Cyltezo Pen 40 MG/0.8 ML Starter Pack - Psoriasis]
RxNorm SynonymCyltezo Pen 40 MG/0.8 ML Starter Pack - Psoriasis/Uveitis (4 count)
Related queriesInteractions (for RxCUI 2640901)



NDC Properties

NDC Item 00597037523

NDC 90597-0375
NDC 100597-0375-23
NDC Item00597037523
Packaging4 KIT in 1 CARTON (0597-0375-23) / 1 KIT in 1 KIT * 1 SYRINGE in 1 TRAY / .8 mL in 1 SYRINGE * 2 PACKET in 1 TRAY / 1 mL in 1 PACKET
BLABLA761058
FDA SPL set id784444
LabelerBoehringer Ingelheim Pharmaceuticals, Inc.
Label typeHUMAN PRESCRIPTION DRUG
Marketing categoryBLA
Marketing effective time low2023-07-01
Marketing statusACTIVE
Related queriesProperties for NDC 9 0597-0375